KINIKSA PHARMACEUTICALS INTE (KNSA) Stock Cash Flow
NASDAQ:KNSA - Nasdaq - GB00BRXB0C07 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.95M | -43.19M | 14.08M | 183.36M | -157.92M | |||
| Depreciation Amortization | 1.57M | 1.70M | 2.34M | 2.40M | 2.36M | |||
| Income Taxes - Deferred | 6.76M | 8.13M | -33.79M | -185.50M | 10.00K | |||
| Change In Working Capital | 17.83M | 24.81M | 1.35M | -22.58M | 690.00K | |||
| Taxes Paid | 5.01M | 2.00M | 5.61M | 10.69M | 1.28M | |||
| Other non cash items | 34.81M | 34.25M | 29.31M | 28.11M | 28.57M | |||
| OPERATING CASH FLOW | 44.03M | 25.69M | 13.30M | 5.81M | -126.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -292.00K | -277.00K | -130.00K | -110.00K | -20.42M | |||
| Other Investing Activity | -39.10M | 37.95M | -29.43M | -7.97M | 149.05M | |||
| INVESTING CASH FLOW | -39.39M | 37.67M | -29.56M | -8.08M | 128.64M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 16.44M | 17.25M | 3.70M | 2.52M | 5.89M | |||
| Other Financing Activity | -5.01M | -4.98M | -2.21M | N/A | N/A | |||
| FINANCING CASH FLOW | 11.42M | 12.27M | 1.50M | 2.52M | 5.89M | |||
| CHANGE IN CASH | 16.05M | 75.63M | -14.76M | 250.00K | 8.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 44.03M | 25.69M | 13.30M | 5.81M | -126.30M | |||
| Capital Expenditure | -292.00K | -277.00K | -130.00K | -110.00K | -20.42M | |||
| FREE CASH FLOW | 43.73M | 25.41M | 13.17M | 5.70M | -146.72M | |||
All data in USD